Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priveterra Acquisition II Unit | PMGMU | May 14, 2024 | 10.96 | 0.00 |
Privia Health Group | PRVA | May 14, 2024 | 18.05 | +0.33 |
Pro-Dex | PDEX | May 14, 2024 | 19.33 | +2.22 |
ProAssurance | PRA | May 14, 2024 | 14.63 | +0.90 |
Procaps Group | PROC | May 14, 2024 | 2.75 | 0.00 |
Procept BioRobotics | PRCT | May 14, 2024 | 65.31 | +2.85 |
Processa Pharmaceuticals | PCSA | May 14, 2024 | 2.18 | -1.80 |
Procore Technologies | PCOR | May 14, 2024 | 67.93 | +0.18 |
Procter & Gamble | PG | May 14, 2024 | 165.76 | -0.07 |
Professional Diversity Network | IPDN | May 14, 2024 | 0.99 | -3.09 |
Proficient Auto Logistics | PAL | May 14, 2024 | 15.19 | 0.00 |
Profire Energy | PFIE | May 14, 2024 | 1.37 | -2.14 |
Profound Medical | PROF | May 14, 2024 | 8.21 | +7.32 |
ProFrac A | ACDC | May 14, 2024 | 8.71 | +9.97 |
PROG | PRG | May 14, 2024 | 35.85 | +0.84 |
Progress Software | PRGS | May 14, 2024 | 51.20 | +0.67 |
Progressive | PGR | May 14, 2024 | 213.67 | +0.59 |
Progyny | PGNY | May 14, 2024 | 27.48 | +0.29 |
Project Energy Reimagined Acquisition A | PEGR | May 14, 2024 | 9.20 | -0.11 |
Project Energy Reimagined Acquisition Unit | PEGRU | May 14, 2024 | 8.99 | 0.00 |
ProKidney | PROK | May 14, 2024 | 4.12 | +33.77 |
Prologis | PLD | May 14, 2024 | 108.28 | +0.56 |
ProMIS Neurosciences | PMN | May 14, 2024 | 1.94 | -3.00 |
PropertyGuru | PGRU | May 14, 2024 | 4.12 | 0.00 |
ProPetro | PUMP | May 14, 2024 | 9.67 | +1.47 |
ProPhase Labs | PRPH | May 14, 2024 | 5.07 | -4.16 |
ProQR Therapeutics | PRQR | May 14, 2024 | 1.99 | +0.25 |
PROS | PRO | May 14, 2024 | 30.91 | +0.91 |
ProShares Bitcoin Strategy ETF | BITO | May 14, 2024 | 24.98 | -2.73 |
Proshares Ultra FTSE Europe | UPV | May 14, 2024 | 66.69 | +1.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.